Cargando…

Small Dense Low-Density Lipoprotein Level in Newly Diagnosed Type 2 Diabetes Mellitus Patients With Normal Low-Density Lipoprotein

Background and objective There are three subtypes of low-density lipoprotein (LDL): large buoyant (lb), intermediate, and small dense (sd). Among these LDL subtypes, small dense low-density lipoprotein (sdLDL) has been proven to be an independent risk factor for atherosclerosis. Type 2 diabetes mell...

Descripción completa

Detalles Bibliográficos
Autores principales:	Juhi, Ayesha, Jha, Kamlesh, Mondal, Himel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2023
Materias:	Cardiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9937031/ https://www.ncbi.nlm.nih.gov/pubmed/36819362 http://dx.doi.org/10.7759/cureus.33924

Ejemplares similares

Small Dense Low-Density Lipoprotein as Biomarker for Atherosclerotic Diseases
por: Ivanova, Ekaterina A., et al.
Publicado: (2017)

Association between measured or calculated small dense low‐density lipoprotein cholesterol and oxidized low‐density lipoprotein in subjects with or without type 2 diabetes mellitus
por: Kim, Hyun‐Ki, et al.
Publicado: (2022)

Role of Different Low-Density Lipoprotein-Lowering Medications on Secondary Prevention of Atherosclerotic Cardiovascular Disease in Patients With Diabetes Mellitus
por: Saag, Jordan L, et al.
Publicado: (2023)

Small, Dense Low-Density Lipoprotein-Cholesterol and Atherosclerosis: Relationship and Therapeutic Strategies
por: Jin, Xiao, et al.
Publicado: (2022)

Small Dense Low-Density Lipoprotein for Risk Prediction of Acute Coronary Syndrome
por: Singh, Abhishek, et al.
Publicado: (2021)

Consuming High-Fat and Low-Fat Ground Beef Depresses High-Density and Low-Density Lipoprotein Cholesterol Concentrations, and Reduces Small, Dense Low-Density Lipoprotein Particle Abundance
por: Lytle, Jason R., et al.
Publicado: (2023)

Small Dense Low‐Density Lipoprotein Cholesterol Is the Most Atherogenic Lipoprotein Parameter in the Prospective Framingham Offspring Study
por: Ikezaki, Hiroaki, et al.
Publicado: (2021)

The influence of triglycerides on small dense low‐density lipoprotein cholesterol levels is attenuated in low low‐density lipoprotein‐cholesterol range: Implications for the negative results of the PROMINENT trial
por: Hirano, Tsutomu, et al.
Publicado: (2023)

Small dense low-density lipoprotein as a potential risk factor of nephropathy in type 2 diabetes mellitus
por: Abd-Allha, Essam, et al.
Publicado: (2014)

Small Dense Low-Density Lipoprotein Cholesterol and Carotid Intimal Medial Thickness Progression
por: Ikezaki, Hiroaki, et al.
Publicado: (2020)

Similarity and differences in small dense low-density lipoprotein assessment: two methods compared
por: Kotani, Kazuhiko, et al.
Publicado: (2021)

Association of Small Dense Low-Density Lipoprotein Cholesterol with Stroke Risk, Severity and Prognosis
por: Zhou, Peiyang, et al.
Publicado: (2020)

Serum concentrations of small dense low‐density lipoprotein cholesterol and lipoprotein(a) are related to coronary arteriostenosis in Takayasu arteritis
por: Chen, Si, et al.
Publicado: (2021)

Atherogenic Plasma Index or Non-High-Density Lipoproteins as Markers Best Reflecting Age-Related High Concentrations of Small Dense Low-Density Lipoproteins
por: Płaczkowska, Sylwia, et al.
Publicado: (2022)

Ipragliflozin lowers small, dense low-density lipoprotein cholesterol levels in Japanese patients with type 2 diabetes mellitus
por: Bando, Yukihiro, et al.
Publicado: (2016)

Predictive value of small dense low-density lipoprotein cholesterol for cardiovascular events in Chinese elder diabetes mellitus patients
por: Xu, Li, et al.
Publicado: (2021)

Small Dense Low-Density Lipoprotein Cholesterol Levels in Breakfast Skippers and Staple Foods Skippers
por: Arimoto, Masako, et al.
Publicado: (2023)

Dapagliflozin decreases small dense low-density lipoprotein-cholesterol and increases high-density lipoprotein 2-cholesterol in patients with type 2 diabetes: comparison with sitagliptin
por: Hayashi, Toshiyuki, et al.
Publicado: (2017)

Are We Nuts Over Coconuts? Studying the Effects of Coconut Oil on Low-Density Lipoprotein and Cardiovascular Diseases: A Systematic Review
por: Sekhar, Supriya, et al.
Publicado: (2022)

Bempedoic Acid’s Use as an Adjunct in Lowering Low-Density Lipoprotein Cholesterol in Patients With Coronary Artery Disease: A Systematic Review
por: Goit, Raman, et al.
Publicado: (2022)

The relationship of low-density lipoprotein cholesterol and all-cause or cardiovascular mortality in patients with type 2 diabetes: a retrospective study
por: Chang, Chin-Huan, et al.
Publicado: (2023)

Inclisiran, Low-Density Lipoprotein Cholesterol and Lipoprotein (a)
por: Katsiki, Niki, et al.
Publicado: (2023)

Chronic kidney disease stage affects small, dense low-density lipoprotein but not glycated low-density lipoprotein in younger chronic kidney disease patients: a cross-sectional study
por: Filler, Guido, et al.
Publicado: (2018)

The association of the Clock 3111 T/C SNP with lipids and lipoproteins including small dense low-density lipoprotein: results from the Mima study
por: Tsuzaki, Kokoro, et al.
Publicado: (2010)

Correction to: Dapagliflozin decreases small dense low-density lipoprotein-cholesterol and increases high-density lipoprotein 2-cholesterol in patients with type 2 diabetes: comparison with sitagliptin
por: Hayashi, Toshiyuki, et al.
Publicado: (2017)

Fatty liver in men is associated with high serum levels of small, dense low-density lipoprotein cholesterol
por: Hosoyamada, Kaori, et al.
Publicado: (2012)

Small Dense Low-Density Lipoprotein Cholesterol and the Risk of Coronary Heart Disease in a Japanese Community
por: Higashioka, Mayu, et al.
Publicado: (2020)

Correlation between small and dense low‐density lipoprotein cholesterol and cardiovascular events in Beijing community population
por: Wang, Xiaona, et al.
Publicado: (2021)

Impact of Pemafibrate Therapy on Reducing Small Dense Low-Density-Lipoprotein-Cholesterol Levels in Patients with Hypertriglyceridemia
por: Hida, Yuki, et al.
Publicado: (2023)

Normal and reconstituted high-density lipoprotein protects differentiated monocytes from oxidized low-density lipoprotein-induced apoptosis
por: Kaur, Navkiran, et al.
Publicado: (2020)

Low density lipoprotein and very low density lipoprotein are selectively bound by aggregated C-reactive protein
Publicado: (1982)

High-density Lipoprotein and Low-density Lipoprotein Therapeutic Approaches in Acute Coronary Syndromes
por: Androulakis, Emmanuel, et al.
Publicado: (2017)

Diabetes mellitus, but not small dense low‐density lipoprotein, is predictive of cardiovascular disease: A Korean community‐based prospective cohort study
por: Suh, Sunghwan, et al.
Publicado: (2013)

Low-Density Lipoproteins Oxidation and Endometriosis
por: Polak, Grzegorz, et al.
Publicado: (2013)

Low-density lipoprotein particles in atherosclerosis
por: Qiao, Ya-Nan, et al.
Publicado: (2022)

Non-high density lipoprotein cholesterol versus low density lipoprotein cholesterol as a discriminating factor for myocardial infarction
por: Sigdel, Manoj, et al.
Publicado: (2012)

A Rare Double Heterozygous Mutation in Low-Density Lipoprotein Receptor and Apolipoprotein B-100 Genes in a Severely Affected Familial Hypercholesterolaemia Patient
por: Juhász, Lilla, et al.
Publicado: (2020)

Small Dense Low Density Lipoprotein Particles Are Associated with Poor Outcome after Angioplasty in Peripheral Artery Disease
por: Jacomella, Vincenzo, et al.
Publicado: (2014)

Small dense low-density lipoprotein cholesterol was associated with future cardiovascular events in chronic kidney disease patients
por: Shen, Hao, et al.
Publicado: (2016)

Small-Dense Low-Density Lipoprotein Cholesterol: A Subclinical Marker for the Primary Prevention of Coronary Heart Disease
por: Kokubo, Yoshihiro, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_q0sna4uh6lkiepi799rmmkcssm